TELEFLEX INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
TELEFLEX INCORPORATED (TFX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $191.51 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-02-27
- TELEFLEX INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2025 was $191.51, a 34.91% decline from fiscal 2024.
- TELEFLEX INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2024 was $294.22, a 7.83% decline from fiscal 2023.
- TELEFLEX INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $319.20, a 11.22% decline from fiscal 2022.
- TELEFLEX INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $359.54, a 7.60% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $191.51 10-K · filed 2026-02-27 |
| 2024-12-31 | $294.22 10-K · filed 2025-02-28 |
| 2023-12-31 | $319.20 10-K · filed 2024-02-23 |
| 2022-12-31 | $359.54 10-K · filed 2023-02-23 |
| 2021-12-31 | $334.14 10-K · filed 2022-03-01 |
| 2020-12-31 | $290.49 10-K · filed 2021-02-25 |
| 2019-12-31 | $245.65 10-K · filed 2020-02-21 |
| 2018-12-31 | $170.78 10-K · filed 2019-02-21 |
| 2017-12-31 | $148.94 10-K · filed 2018-02-22 |
| 2016-12-31 | $125.71 10-K · filed 2017-02-23 |
| 2015-12-31 | $103.42 10-K · filed 2016-02-25 |
| 2014-12-31 | $87.37 10-K · filed 2015-02-20 |
| 2013-12-31 | $65.79 10-K · filed 2014-02-24 |
| 2012-12-31 | $60.50 10-K · filed 2013-02-22 |
| 2011-12-31 | $60.44 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |